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the molecular basis of thioalcohol 
production in human body odour
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Body odour is a characteristic trait of Homo sapiens, however its role in human behaviour and 
evolution is poorly understood. Remarkably, body odour is linked to the presence of a few species of 
commensal microbes. Herein we discover a bacterial enzyme, limited to odour-forming staphylococci 
that are able to cleave odourless precursors of thioalcohols, the most pungent components of body 
odour. We demonstrated using phylogenetics, biochemistry and structural biology that this cysteine-
thiol lyase (C-T lyase) is a PLP-dependent enzyme that moved horizontally into a unique monophyletic 
group of odour-forming staphylococci about 60 million years ago, and has subsequently tailored its 
enzymatic function to human-derived thioalcohol precursors. Significantly, transfer of this enzyme 
alone to non-odour producing staphylococci confers odour production, demonstrating that this 
C-T lyase is both necessary and sufficient for thioalcohol formation. The structure of the C-T lyase 
compared to that of other related enzymes reveals how the adaptation to thioalcohol precursors 
has evolved through changes in the binding site to create a constrained hydrophobic pocket that is 
selective for branched aliphatic thioalcohol ligands. The ancestral acquisition of this enzyme, and the 
subsequent evolution of the specificity for thioalcohol precursors implies that body odour production 
in humans is an ancient process.
Human body odour is produced by bacterial transformation of odourless precursor molecules secreted onto 
the surface of the skin by apocrine  glands1-3. These glands are one of two major types of sweat gland found in 
Homo sapiens, the other being the eccrine glands. Eccrine glands are found in high density all over the body, they 
open directly onto the surface of the skin and are essential for  thermoregulation4 (Fig. 1A). In contrast, apocrine 
glands open into hair follicles and typically occur in high density at specific body sites (axilla [underarm], nipple 
and external genitalia) (Fig. 1A); their exact function and physiological role in modern humans remain poorly 
understood. The axillary microbiota plays an important role in the generation of human body odour. Staphylo-
coccus, Cutibacterium (formerly Propionibacterium) and Corynebacterium are the dominant genera colonizing 
the  axilla5,6, with recent metataxonomic studies highlighting the additional presence of Gram-positive anaerobic 
cocci (GPAC), notably Anaerococcus and Peptoniphilus  species5,7. Human axillary malodour is comprised of 
a mixture of volatile organic compounds with volatile fatty acids (VFAs) and thioalcohols being the primary 
components (Supplementary Information Figure S1)8–10. Thioalcohols, despite being present in trace amounts, 
are the most pungent  voaltiles9. Natsch et al.2,11 identified trace amounts of four different thioalcohols in axillary 
secretions with 3-methyl-3-sulfanylhexan-1-ol (3M3SH) being the most abundant. 3M3SH is generated from 
the odourless precursor Cys-Gly-3M3SH, an l-cysteinylglycine dipeptide-conjugated alcohol that is secreted 
onto the surface of the skin by apocrine  glands12. We and others have shown that a limited number of axillary 
staphylococcal species take up and metabolise Cys-Gly-3M3SH3. The precursor enters the cell through a proton-
coupled oligopeptide di-/tripeptide transporter (DtpT) which is conserved across all staphylococcal  species13, 
meaning it cannot be a unique requirement for thioalcohol production. The presumed biochemical pathway for 
Cys-Gly-3M3SH biotransformation following its uptake is sequential metabolism by a dipeptidase to release 
glycine and cleavage by a C-S β-lyase to liberate the volatile 3M3SH (Fig. 1A); to date, the enzymes involved have 
not been identified in odour producing staphylococci. Here, we describe the biochemical basis of thioalcohol 
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formation through our identification and structural characterisation of a unique intracellular enzyme essential 
for 3M3SH liberation in the odour-forming species Staphylococcus hominis. Using a combination of structural 
biology and biochemistry, we demonstrate how this enzyme is substrate selective for the thioalcohol precursor 
Cys-3M3SH. This represents a new level of understanding on how specific microbes biochemically contribute 
to axillary malodour, an essential prerequisite for more targeted strategies to inhibit body odour. 
Results
Discovery of a unique C-S lyase involved in the formation of body odour. By screening a range 
of axillary Staphylococcus species and strains, we identified those coagulase negative staphylococci (CoNS) 
able to take up and convert Cys-Gly-3M3SH to 3M3SH (Fig. 1B and Supplementary Information Figure S2A). 
Among these, a monophyletic group of CoNS emerged as the most efficient biotransfomers of Cys-Gly-3M3SH 
(Fig. 1B Group 1 [G1]), along with Staphylococcus species from two other distinct clades (Fig. 1B Groups 2 and 
3 [G2&G3]). Strikingly, Staphylococcus epidermidis, the dominant staphylococcal species present on the skin 
including the  axilla14, does not metabolise Cys-Gly-3M3SH (Fig. 1B, Supplementary Information Figure S2B 
and C), and nor do other species of human associated staphylococci such as Staphylococcus capitis and Staphy-
lococcus aureus (Fig. 1B; Supplementary Information Figure S2C). The G1 clade contains S. hominis, a species 
which is strongly associated with body odour, along with Staphylococcus lugdunensis and Staphylococcus haemo-
Figure 1.  A unique clade of Staphylococcus spp. produce human malodour. (A) Overview of bacterial 
biotransformation of the odourless physiological malodour precursor Cys-Gly-3M3SH. Cys-Gly-3M3SH is 
secreted onto the surface of skin by axillary apocrine glands, subcutaneously located in the hypodermis. In 
Staphylococcus hominis, Cys-Gly-3M3SH is actively transported by the di-/tri-peptide transporter (DtpT) along 
with the movement of protons (1). Once inside the cell the terminal glycine is cleaved by a dipeptidase (PepA) 
to release Cys-3M3SH (2), which is metabolised by a C-S β-lyase liberating volatile 3M3SH (3), which diffuses 
or is exported out of the cell (4). The catabolism of Cys-Gly-3M3SH provides carbon and nitrogen as nutritional 
incentive in the form of glycine, ammonia and pyruvate. (B) Core genome phylogeny of staphylococcal species. 
Maximum Likelihood (ML) phylogenetic tree based on 53 representative species of staphylococci. Coloured 
strips represent the species group indicated in the colour key. Presence or absence of PLP-DE genes is indicated 
by filled (present)/unfilled (absent) circles. DtpT: di-/tri- peptide transporter; PepA: Aminopeptidase A; MetC: 
Cystathionine-β-lyase; PatA: Aspartate Aminotransferase; PatB: Putative Cysteine-S-conjugate β-lyase. Bars 
represent in vivo biotransformation of Cys-Gly-3M3SH by Staphylococcus spp. Biotransformation is quantified 
by release of 3M3SH labelled with DTNB and measured by absorbance at 412 nm. Groups of staphylococcal 
PatB enzymes are denoted by G1, G2 and G3. Phylogenetic tree and bar chart was generated using iTOL (https 
://itol.embl.de/).
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lyticus, which have been previously linked to thioalcohol  production3. In order to elucidate the molecular basis 
for this highly limited phenotype in staphylococci, we searched staphylococcal genomes for enzymes likely to 
be involved in the generation of volatile thioalcohols. All staphylococcal genomes encode a DtpT orthologue, 
involved in precursor  uptake15 and PepA, the likely peptidase required for removal of the glycine from the Cys-
Gly-3M3SH (Fig. 1A, B), so we reasoned that the lyase step would be unique. Cleavage of Cys-3M3SH to pro-
duce 3M3SH involves a β-elimination from an amino acid substrate. As this type of chemistry is most commonly 
performed by enzymes containing pyridoxal phosphate (PLP), we focused our search on unusually distributed 
PLP-dependent enzymes (PLP-DEs) present in  staphylococci9 including PLP-DEs from the Cys/Met metabo-
lism family. All staphylococci contain orthologues of MetC, a cystathionine β-lyase that converts cystathionine 
to homocysteine as the penultimate step in methionine  biosynthesis16. Previous work demonstrated that MetC 
from S. haemolyticus, a species in the G1 clade, does not catalyse Cys-3M3SH cleavage, suggesting another 
PLP-DE is  responsible17. Orthologues of another PLP-DE identified in Bacillus subtilis, the putative aspartate 
transaminase  PatA18 (Fig. 1B), are ubiquitously distributed in staphylococci. However, a second related protein, 
known as PatB in B. subtilis, is present in a small number of staphylococci only (Fig. 1B). In fact, the occurrence 
of a gene encoding this protein correlates precisely with the detection of Cys-Gly-3M3SH breakdown in our 
in vivo biotransformation assay (Fig. 1B). While the PatB enzymes are poorly characterised and the genes are 
not associated with amino acid metabolism gene clusters or  operons19, the orthologues from B. subtilis (PatB) 
and Escherichia coli (MalY) are known to have cystathionine β-lyase  activity19,20, suggesting that these enzymes 
might also be capable of Cys-3M3SH cleavage.
Mapping the few examples of staphylococcal PatB-like enzymes onto the global phylogeny of the Staphylococ-
cus genus, suggests that horizontal gene transfers into staphylococcal lineages occurred on three independent 
occasions with the earliest being into an ancestor of G1, likely from a Bacillus-like ancestor (Fig. 2). This clade 
of PatB-containing staphylococci includes S. hominis, a strong producer of thioalcohol-based malodour, and its 
signature enzyme, which we named ShPatB, was thus studied further. Core genome analysis reveals ShPatB is 
a conserved core gene present in S. hominis (Supplementary Information Figure S3). To test whether ShPatB is 
important for malodour production, we expressed the gene in a non-malodour producing strain of S. aureus and 
were able to measure 3M3SH production in vivo (Supplementary Information Figure S2 D). This demonstrates 
that ShPatB is both necessary and sufficient for thioalcohol-based odour production in the human underarm 
(Fig. 1A, B).
ShPatB is selective for branched aliphatic thioalcohol ligands. Next, we cloned and overexpressed 
genes encoding a representative range of PatB-type enzymes, with two MetC proteins as controls (Fig. 2, denoted 
by coloured dots) and purified the proteins for biochemical analysis. We compared the catalytic efficiencies 
 (kcat/KM) of these 12 PLP-DEs for the malodour substrate Cys-3M3SH and the classical C-S lyase substrate 
cystathionine (Fig. 3). We observe distinct clusters of catalytic activity, with G1 PatB enzymes showing higher 
activity against the malodour substrate Cys-3M3SH compared to all the other PLP-DEs (Fig. 3). In particular, 
ShPatB exhibits selectivity towards Cys-3M3SH with a catalytic efficiency 138-fold higher that that towards 
cystathionine (766 M−1 min−1 and 5.53 M−1 min−1, respectively) (Fig. 3, Supplementary Information Figure S4, 
Table S1 and Table S2). The staphylococcal PatB-like enzymes from G2 and G3 species show very low activity 
towards Cys-3M3SH, suggesting that they do not contribute significantly to body odour formation given the 
likely micromolar concentrations of precursor present in the axilla (Fig. 3). The PatB enzymes from non-axillary 
microbes B. subtilis (BsPatB) and Streptococcus anginosus (SaPatB) did not discriminate between the two ligands 
(Fig. 3), while the enzymes from Corynebacterium jeikeium (CjAecD) and E. coli MalY (EcMalY) had higher 
activities against cystathionine, similar to the MetC enzymes included (ShMetC and SeMetC), which have little 
or no activity against Cys-3M3SH (Fig. 3 and Supplementary Information Figure S4). We also measured enzyme 
activity against Felinine, a close structural analog of Cys-3M3SH and a putative pheromone precursor found in 
cat  urine21, and observed a very similar activity profile to that seen for Cys-3M3SH (Supplementary Information 
Figure S4, Table S3). Compared to cystathionine, the malodour precursors differ significantly in the side chains 
attached to the cysteine thiol, these being branched and hydrophobic, rather than linear with ionisable amino 
and carboxylate groups which are expected to be charged at physiological pH (Supplementary Information Fig-
ure S4). As ShPatB and G1 PatB enzymes have novel selectivity for cysteine-conjugated thioalcohol ligands, we 
propose that these enzymes are cysteine-thiol lyases (C-T lyases) distinct from C-S lyases acting on a broad 
range of cysteine-conjugated ligands (such as BsPatB and CjAecD).
Structural characterisation reveals a hydrophobic thioalcohol binding pocket. To explore the 
structural basis of ShPatB selectivity for these more hydrophobic malodour precursors compared to the broader 
C-S lyase substrate activity of BsPatB, crystal structures of the two proteins were solved and refined to resolu-
tions of 1.6 Å (PDB ID 6QP2) and 2.3 Å (PDB ID 6QP3) respectively (Supplementary Information Figure S5A, 
B). ShPatB and BsPatB are homodimeric with each subunit containing a PLP moiety covalently bound to a 
conserved lysine residue in the catalytic site (Lys246 and Lys234 in ShPatB and BsPatB, respectively) in what 
is termed the internal aldimine state (Supplementary Information Figure  S5 A and B). Overall, ShPatB and 
BsPatB are structurally conserved and belong to the type onefold of PLP-DEs22 (Supplementary Information 
Figure S5D). Absorption spectra indicate the presence of PLP (410 nm) covalently bound to ShPatB (Supple-
mentary Information Figure  S6A). We note, upon addition of Cys-3M3SH and additional peak at ~ 500  nm 
concomitant with a decrease at 410 nm (Supplementary Information Figure S6B), this species is most likely the 
external aldimine intermediate. A peak in this range typically indicates the presence of a PLP intermediate and 
is observed in cystathionine β-lyases23. After 30 s the peak reduces with a slight increase at 410 nm. As ShPatB is 
4Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:12500  | https://doi.org/10.1038/s41598-020-68860-z
www.nature.com/scientificreports/
Figure 2.  Malodour producing staphylococci contain a unique C-S lyase enzyme. Maximum likelihood tree 
of PLP dependent C-S lyases from representative bacterial species. A unique PLP dependent PatB enzyme 
is found in a distinct phylogenetic clade of staphylococcal species, which we refer to as malodour producing 
staphylococci (coloured orange, G1). Coloured dots represent selected PLP-dependent enzymes purified for 
further biochemical characterisation. Orthologous PatB enzymes found in other Staphylococcusal spp. are 
indicated by G1, G2 and G3. Phylogenetic tree was generated using iTOL (https ://itol.embl.de/).
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a β-C-S lyase we do not see any activity with l-methionine which is a γ-lyase substrate (Supplementary Informa-
tion Figure S6C).
In the course of a typical PLP-DE catalysed reaction, upon substrate binding, the ε-amino group of the amino 
acid substrate displaces the lysine residue from the PLP to form an external  aldimine24–26 (Supplementary Infor-
mation Figure S8). The PLP and the α-amino group of the displaced lysine next facilitate electron pair and proton 
shuttling that lead to breakage of the C-S bond and release of 3M3SH (see Supplementary Information Figure S8 
for suggested mechanism). We made several attempts to crystallise ShPatB and subsequent ShPatB catalytic 
mutants in the presence of the ligand Cys-3M3SH but were unable to obtain crystals suitable for X-ray structure 
determination. As we were unable to capture reaction intermediates by soaking ShPatB or BsPatB crystals with 
Cys-3M3SH, we sought insight into the mode of substrate binding by growing crystals of ShPatB in the presence 
of l-cycloserine (LCS). LCS is a known PLP-DE  inhibitor27, that forms an external aldimine complex with PLP 
thereby inhibiting ShPatB (Fig. 5A, B). The structure solved at 1.4 Å (PDB ID: 6QP1) confirms the formation of 
the external aldimine and reveals the LCS and PLP interacting residues in the binding pocket of ShPatB (Fig. 4A, 
B, D and Supplementary Information Figure S5C). Mutation of key conserved PLP and LCS interacting residues 
reduced activity both in vitro and in vivo (Figs. 4E and 5D, E), demonstrating their important roles in binding 
and  catalysis24. Supplementary Information Table S4 summarises the steady state kinetics for all ShPatB mutants 
analysed for Cys-3M3SH in vitro biotransformation. Common to PLP-DEs, a highly conserved arginine residue 
(Figs. 4B and 5A, C) forms an ion-pairing interaction with the carboxylate group of the amino acid moiety of the 
various amino acid  substrates22,28,29. In ShPatB, we infer this arginine to be Arg376 (Supplementary Information 
Figure S5A); in the structure of the inhibitor complex, it forms a polar interaction with the C=O of LCS and is 
well-positioned to form a salt-bridge with the Cys-3M3SH adduct. Moreover, substitution of this residue with 
alanine abolishes activity both in vitro and in vivo (Figs. 4E and 5E, respectively). 
While the reaction mechanism of PLP-DEs action is well established, determining the substrate specificity 
of novel PLP-DEs remains a major  challenge24. To gain insights into ShPatB selectivity we modelled the struc-
ture of the external aldimine form of the enzyme bound to Cys-3M3SH. The PLP adduct of Cys-3M3SH was 
superimposed onto equivalent atoms of the LCS external aldimine bound to ShPatB so that the α-carboxylate 
of the substrate forms the conserved ion-pairing interaction with Arg376. In this conformation, the side chain 
of Cys-3M3SH projects from the deeply recessed PLP binding pocket towards the protein surface (Fig. 4C and 
Supplementary Information Figure S7A and B). The aliphatic 3M3SH species fits, with minimal steric hindrance, 
Figure 3.  Malodour producing staphylococci PatB enzymes are selective for Cys-3M3SH. Comparison of 
catalytic efficiencies  (Kcat/KM) for selected PLP dependent C-S lyases against classical C-S lyase substrate 
l-cystathionine (y-axis) and l-Cys-3M3SH (x-axis). We show distinct clusters of activity across the PLP-DEs. 
MetC enzymes are selective for cystathionine only while G1 malodour-producing staphylococci are substrate 
selective for Cys-3M3SH, we now classify these enzymes as cysteine-thiol lyases. Other PatB orthologs (blue) 
display activity across both substrates whereas orthologous PatB enzymes from staphylococci (G2 & G3) show 
little or no activity with either substrates. Groups of staphylococcal PatB enzymes are highlighted.
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into a spacious apolar pocket formed by the side chains of Tyr25, Val46, Tyr72, Val108, Pro134,Phe274 and Thr276 
(where italics denotes a residue from the partner subunit of the dimer) (Fig. 4C). The hydrophobic character 
of this pocket provides few, if any, polar groups to form interactions with the side chain of cystathionine which 
would be expected to be zwitterionic at physiological pH (Fig. 4C, D). As a result, cystathionine binding would 
be accompanied by the development of unsolvated, or poorly solvated charge, lowering affinity and accounting 
for discrimination against this substrate as observed in our kinetic data (Fig. 3). We suggest that the hydrophobic 
character of this pocket accounts for the selectivity toward malodour substrates. To test this, we measured the 
kinetics of the ShPatB catalysed reaction with a range of cysteine-S conjugate ligands that varied in side chain 
length, the presence or absence of side chain branching, and side chain polarity. ShPatB clearly prefers branched 
aliphatic side chains followed by linear hydrophobic side groups while excluding linear charged ligands (Fig. 6B). 
This structural accommodation of malodour substrates represents a unique evolutionary trajectory for ShPatB 
not seen in other reported PatB enzymes to date.
To gain insights into this constrained substrate binding site in ShPatB, we examined a unique tyrosine residue 
(Tyr25) that extends into the active site in each subunit with the phenolic side chain projecting towards the PLP 
moiety (Figs. 4A and 6C). Tyr25 is part of a sequence divergent N-terminal region, and this residue is found only 
in malodour producing staphylococci (Fig. 6D). This N-terminal region is often unresolved in PLP-DE structures, 
and indeed, we could resolve this region only in the  ShPatBLCS structure. The introduction of a Tyr25Ala sub-
stitution resulted in a sixfold increase in  KM, significantly affecting Cys-3M3SH binding compared to wild-type 
ShPatB (Fig. 4E). We hypothesise that Tyr25 contributes to a specific hydrophobic surface in ShPatB, absent in 
BsPatB and other PLP-DEs (Figs. 4C and 6C), that efficiently orientates the 3M3SH moiety. In contrast to ShPatB, 
the BsPatB binding cavity is more solvent exposed and composed of charged residues (Fig. 4D), thus enabling 
the binding of polar substrates like cystathionine and the hydroxyl group of the 3M3SH moiety of Cys-3M3SH.
Supporting this, the substitution of Tyr25 to a similarly hydrophobic phenylalanine (Tyr25Phe) does not 
significantly affect Cys-3M3SH binding (Fig. 4E). The shape of the hydrophobic pocket is critical for Cys-3M3SH 
Figure 4.  Structural characterisation of ShPatB binding site. (A) Homodimeric structure of ShPatB. Both 
surface and ribbon representation are shown. (B) Zoomed view of ShPatB bound in complex with cycloserine 
(PDB ID 6QP1). l-cycloserine is shown in the external aldimine form bound to PLP. Coloured residues Y72 
T276 denote chain A while all other residues are from chain B. (C) Modelled Cys-3M3SH complex in  ShPatBLCS 
structure. The Cys-3M3SH ligand is modelled in the external aldimine form and docked onto the  ShPatBLCS 
structure. Cys-3M3SH is coordinated by conserved ion pairing of its carboxylate group with the side chain of 
Arg376. (D) Electrostatic surface potential for  ShPatBLCS and BsPatB respectively. Zoomed in views of the active 
site indicating the possible role of Y25 in mediating apolar interactions. In the 90 °C rotated view, we clearly see 
a narrow hydrophobic pocket in wild-type ShPatB whereas BsPatB lacking Y25 appears to have a more solvent 
accessible exposed binding site. (E) In vitro kinetics of ShPatB mutants. Mutagenesis highlights the importance 
of the conserved PLP interacting and ligand binding residues while revealing the importance of Y25 and E362. 
All structural images were generated in CCP4MG (https ://www.ccp4.ac.uk/MG/).
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Figure 5.  Functional analysis of ShPatB active site variants. (A) Schematic diagram of ShPatB + cycloserine 
complex. PLP interacting residues are indicated in yellow and ligand interacting residues are in blue. (B) 
Cycloserine in vitro inhibition of ShPatB with Cys-3M3SH as the substrate. End point in vitro biotransformation 
assay of ShPatB (2.5 μM) incubated with Cys-3M3SH (2.5 mM) in the presence or absence of cycloserine. 
Release of 3M3SH was labelled with DTNB and absorbance measured at 412 nm (y-axis). Cycloserine was 
thought to bind irreversibly to  PLP27 to inactivate ShPatB however, we show that inhibition is reversed by excess 
PLP thus regenerating ShPatB for catalysis of Cys-3M3SH. (C) Multiple sequence alignment of C-S-β-lyases 
showing conserved PLP and ligand interacting residues. (D) In vivo biotransformation of Cys-3M3SH with 
ShPatB binding site PLP mutants and (E) ShPatB ligand interacting residues. Phylogenetic tree was generated 
using iTOL (https ://itol.embl.de/).
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Figure 6.  ShPatB is selective for aliphatic cysteine-S-conjugates. (A) ShPatB and other G1 PatB enzymes 
contain unique hydrophobic residues. (B) Catalytic efficiencies  (Kcat/KM) show that ShPatB has significantly 
higher activity for aliphatic cysteine-S-conjugate substrates compared to BsPatB. We hypothesise that unique 
hydrophobic residues (Tyr25 and Phe274) found only in malodour producing staphylococci mediates apolar 
contacts hence increased selectivity of ShPatB for these substrates. PSA indicates polar surface area calculated 
by BIOVA Draw 2018. (C) Structural comparison of ShPatB N-terminal region with BsPatB. BsPatB lacks 
equivalent Tyr25 found in ShPatB and does not provide a hydrophobic pocket. (D) ShPatB contains a highly 
variable region located at N-terminus. Structural sequence alignments shows a highly divergent N-terminal 
region between malodour producing staphylococci and orthologs. Y25 is coloured orange in malodour 
producing staphylococci. Red background indicates strictly conserved, red text—highly similar. The alignment 
was generated using MAFFT-LiNS in Jalview (https ://www.jalvi ew.org/) the graphic was prepared on the 
ESPript 3.0 server (https ://espri pt.ibcp.fr/ESPri pt/cgi-bin/ESPri pt.cgi). Phylogenetic trees were generated using 
iTOL (https ://itol.embl.de/).
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binding; mutating Thr276 to Ala resulted in an 8.5-fold increase in ShPatB  KM for Cys-3M3SH (Fig. 4E). Within 
the neighbourhood of this apolar pocket, we observe hydrophobic residues (Tyr25, Phe274) that are unique to 
malodour producing staphylococci (Fig. 6A). Taken together, our observations suggest that the hydrophobic 
binding site in ShPatB is a key determinant of this enzyme’s selectivity towards malodour-producing substrates.
Evolutionary phylogeny of malodour producing staphylococci. As noted previously (Fig. 2), the 
distribution of PatB enzymes among staphylococci is limited to a handful of species. In contrast, they have a 
much broader distribution across the Bacillus genus suggesting an ancient horizontal gene transfer (HGT) event 
into staphylococci. From our phylogenetic analysis, we infer this happened at least three times in staphylococci 
(Fig. 2), although only one of these events occurred in human associated staphylococci and led to an enzyme 
with high activity against Cys-3M3SH with counter selectivity against cystathionine (the G1 PatB enzymes). As 
the G1 enzymes are present in species that form a clear monophyletic group of staphylococci, we attempted to 
date the split of this clade from the other non-odour producing staphylococci to age the process of thioalcohol 
production. In order to determine the evolutionary phylogeny, we generated a core genome alignment of repre-
sentative Staphylococcus sp. (1B). This core genome alignment was used to infer a time-scaled evolutionary phy-
logeny of Staphylococcus species. We used Bayesian analysis to estimate Staphylococcus species divergence time 
(Supplementary Information Figure S9). For the temporal scale, we used the divergence time between Staphy-
lococcus warneri and Staphylococcus pasteuri estimated from the TimeTree  database30. We show the appear-
ance and diversification of malodour producing staphylococci from the most recent common ancestor (MRCA) 
approximately 60 million years ago (MYA) (95% highest posterior density (HPD) 45–89 MYA) (Fig. 7). This 
would imply that the emergence of this process in the staphylococcal population occurred around the same time 
as the early divergence of primates and the appearance of the suborder  Haplorhini31. While several studies have 
characterised the human skin microbiome (reviewed by Grice and  Segre32) relatively little is known about the 
composition of non-human mammals, especially using next-generation sequencing technologies. Humans have 
a distinct axillary microbiota that is typically less diverse compared to other primates. However, Council et al.33 
Figure 7.  Divergence time and evolution of Staphylococcus spp. Bayesian maximum clade credibility tree 
for representative Staphylococcus spp. based on core genome sequences. Branch lengths are proportional to 
divergence times (millions of years ago, MYA). Blue bars represent 95% highest posterior density of node age. 
Our data show the diversification of malodour producing staphylococci approximately 60 MYA. Phylogenetic 
tree was generated using FigTree V1.4.4 (https ://tree.bio.ed.ac.uk/softw are/figtr ee/).
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showed that, in the absence of antiperspirant or deodorant usage, humans share a similar axillary microbiome 
to apes. They identified a core axillary microbiome dominated by Corynebacterium along with Anaerococcus, 
Prevotella and Staphylococcus as the most abundant taxa. While there is certainly error in this estimate of 60 
MYA, we believe that the most parsimonious explanation is that this malodour producing group of staphylo-
cocci was associated with the ancestral populations of humans going back towards the divergence of primates.
Discussion
Human body odour is produced by the bacterial metabolism of odourless secretions from the apocrine gland. The 
role of the axillary microbiota in the formation body odour has long been  established1,9; however, the molecular 
basis of malodour pathways from resident axillary microbes has not been fully elucidated. Thioalcohols, along 
with VFAs, are the primary components of axillary  malodour8,9. Until now, the identification of the enzyme 
responsible for the C-S cleavage of thioalcohol precursors such as Cys-3M3SH was unknown. Initially, the C-S 
lyase activity was attributed to Corynebacterium  species2,9; however, Bawdon et al.3 later demonstrated that S. 
hominis, S. lugdunensis and S. haemolyticus, but not Corynebacterium species, metabolised the physiological 
dipeptide malodour precursor Cys-Gly-3M3SH. Here, we show these Staphylococcus species form a distinct 
monophyletic group; we also show that other Staphylococcus species present within this group are capable of 
thioalcohol production, which was previously unknown (Supplementary Information Figure S2C). This is in 
agreement with Starkemann et al.34 who identified S. haemolyticus as an efficient biotransformer of Cys-Gly-
3M3SH in contrast to other axillary species including S. epidermidis and corynebacteria. Initial attempts to 
identify the C-S lyase pinpointed several MetC- and MalY-type enzymes, although Troccaz et al.17 clearly dem-
onstrated that staphylococcal MetC enzymes are not involved in the formation of volatile sulphur compounds. 
Subsequently, the MalY-type C-S lyase AecD from corynebacteria was associated with precursor cleavage and 
subsequent thioalcohol-based odour  formation9.
In this study, we identify PatB in S. hominis as the C-S lyase responsible for thioalcohol liberation from Cys-
3M3SH. To date, this is the first structural characterisation of the thiol-based axillary malodour pathway in S. 
hominis. ShPatB is a MalY-type enzyme that is uniquely distributed among staphylococci; we observed orthologs 
present in three groups of Staphylococcus species (clades G1, G2 G3). We kinetically characterised these PatB 
C-S lyases from staphylococci in vitro, alongside MetC-type and other MalY-type PatB PLP-DEs with previ-
ously reported C-S lyase activity. Our results demonstrate the PatB enzymes from G1 staphylococci are selective 
for the malodour substrate Cys-3M3SH over the typical C-S lyase substrate cystathionine, compared to other 
PatB enzymes. ShPatB has the highest catalytic efficiency for Cys-3M3SH, 5.5 fold higher than CjAecD from 
C. jeikeium. We also showed that CjAecD is selective for cystathionine over Cys-3M3SH, in agreement with its 
role in methionine biosynthesis in Corynebacterium  species35. Given that corynebacteria cannot metabolise the 
dipeptide thiol precursor in vivo, their role in thioalcohol production in the axilla would appear to be limited.
The structure of ShPatB provided significant insights into how this enzyme has evolved selectivity for the thiol 
precursor Cys-3M3SH. ShPatB is a PLP-DE, with a core active site that is structurally conserved across all C-S 
lyases (Supplementary Information Figure S5C); however, ShPatB contains a hydrophobic pocket comprising 
unique residues not found in any other PatB enzymes other than malodour producing staphylococci (Fig. 6). 
This hydrophobic pocket in ShPatB is essential for Cys-3M3SH selectivity. Our phylogenetic analyses suggest 
ShPatB may have evolved from a common ancestor (Fig. 2). Despite sharing high structural similarity to closely 
related orthologs, we observed significant differences in substrate activity among these MalY-type PatB enzymes. 
In contrast to the roles of other MalY-type PatB enzymes as redundant MetC replacements in sulphur-containing 
amino acid  metabolism18,23,35, ShPatB is selective for aliphatic cysteine-S-conjugates only, while discriminating 
against polar ligands such as cystathionine.
The composition of the modern human axilla is considered unique in composition and diversity relative 
to other  primates33. The increasing abundance of Staphylococcus  species6,32 can be considered indicative of an 
evolutionary trajectory toward modern humans. The abundance of staphylococci in the axilla is dominated by 
S. epidermidis5; indeed, the phylogeny of Staphylococcus species suggests that the human associated species S. 
epidermidis and S. aureus are the most recently diversified, based on our analysis (Fig. 7), while the appearance 
and diversification of malodour producing staphylococci occurs approximately 60 MYA. While we recognise 
the error in these estimates, we propose that the most parsimonious explanation is that this group of malodour 
producing staphylococci must have been present in ancestral human populations potentially dating back to 
primates. Based on this assumption, we suggest that thioalcohol production predates the emergence of Homo 
sapiens as a species.
This discovery raises important questions about the role of odour production in the evolution of modern 
humans. The emergence of an enzyme present in bacteria found in the human underarm with unique activity to 
catalyse production of 3M3SH suggests selection pressure for the production of odours over an extended period 
of evolutionary time. This was presumably driven by an evolutionary advantage for both the host (primate, 
human), that actively produces the odour precursors for no other apparent physiological reason, and their micro-
biota, which converts them to volatile odorous molecules. Here, we have identified a definite substrate-product 
relationship, namely the conversion of specific thioalcohol precursors by malodour producing staphylococci. We 
show that S. epidermidis unequivocally does not metabolise these precursors, despite being the most abundant 
Staphylococcus species present in the axilla. Could these thioalcohol precursors secreted by the apocrine sweat 
glands be significant for the ecological success of S. hominis in the human axilla? This raises important and as 




Scientific RepoRtS |        (2020) 10:12500  | https://doi.org/10.1038/s41598-020-68860-z
www.nature.com/scientificreports/
Methods
Bacterial strains, media, reagents, chemicals and plasmids. All bacterial strains and plasmids used 
in this study are listed in Supplementary Information Table S6 and Table S7 respectively. Most of the Staphylo-
coccus strains were isolated during a Unilever human axillary malodour project. Dr Malcom Horsburgh (Uni-
versity of Liverpool) kindly provided a number of Staphylococcus strains. All standard chemcials and buffers 
were purchased from Sigma-Aldrich. DTNB, PLP and S-Benzyl-l-cysteine were purchased from Sigma-Aldrich. 
Physiological malodour substrates Cys-Gly-3M3SH and Cys-3M3SH were custom synthesised by Concept Life 
Sciences. Stock concentrations were prepared at 10 mM in M9 buffer.
Cloning, expression and purification of C-S lyase proteins. C-S lyase proteins for purification were 
cloned into the expression vector pBADcLIC with a C-terminal Hisx10 tag under the control of arabinose. Full 
length proteins were either amplified by PCR or synthesised as gBlock (IDT) fragments. For PCR amplification, 
full-length genes were amplified by PCR from the host organism with additional overhangs for cloning (final 
recombinant protein MGGGFA <INSERT> ENLYFQGHHHHHHHHHH*). PCR fragments were purified and 
cloned into pBADcLIC by standard ligation-independent cloning (LIC). Oligonucleotides were purchased from 
Sigma-Aldrich. For protein expression, all pBAD plasmids were transformed into E. coli MC1061. For overex-
pression of C-S lyases proteins, overnight cultures of E. coli MC1061 harbouring a pBAD plasmid expressing a 
C-S lyase were grown in LB at 37 °C, 200 rpm. Overnight cultures were diluted to an  A600nm 0.05 in 1-L LB sup-
plemented with 100 mg mL−1 ampicillin. Cultures were incubated at 37 °C, 200 rpm to OD600nm 0.4–0.5 and 
induced by addition of 0.01% arabinose. After 8 h expression, cells were harvested by centrifugation at 5,000 g for 
15 min, resuspended in 35 mL resuspension buffer (50 mM Potassium Phosphate (KPi), 20% glycerol, 200 mM 
NaCl and 10 mL imidazole, pH 7.8), and stored at -80 °C. All subsequent steps were carried out at 4 °C. Resus-
pended cells were thawed and supplemented with 1 mM AEBSF protease inhibitor (Thermo Fisher Scientific). 
Cells were lysed by sonication (3 s pulse, 7 s pause – 3 min). Lysates were clarified by centrifugation at 27,000g 
for 30 min. The clarified supernatant was loaded onto a 5 mL HisTrap column (GE Healthcare) and affinity puri-
fied on an AKTA Start (GE Healthcare) using a standard protocol as per manufacturer’s instructions. Fractions 
were pooled and concentrated to 15–20 mg mL−1 for crystallisation or biochemical kinetic assays. Proteins were 
stored in 50 mM KPi and 200 mM NaCl. For crystallography experiments proteins were stored in 20 mM Tris, 
pH8 and 50 mm NaCl.
ShPatB site-directed mutagenesis. Site directed mutagenesis was used to generate variants of S. homi-
nis PatB for kinetic analyses. Native ShPatB cloned into pBADcLIC was used to individually generate targeted 
mutants. To introduce the mutation, high fidelity inverse PCR was performed using divergent primers with one 
per pair being mutagenic. Mutagenic PCR products were circularised by blunt end ligation. All mutants were 
verified by Sanger sequencing (GATC Biotech). ShPatB variants were transformed into E. coli MC1061 for pro-
tein expression and into E. coli BW25113 for in vivo kinetic analyses.
In vivo Cys-Gly-3M3SH biotransformation assays. Resting cells were used for in vivo biotransforma-
tion of the malodour precursor Cys-Gly-3M3SH. Overnight cultures were harvested by centrifugation at 3,000g 
for 10 min and resuspended in sterile M9 buffer. Cells to an  OD600nm of 5 were added to 2.5 mM substrate and 
M9 to a final volume of 200 μL. Reactions were incubated at 37 °C for 5 h. Liberated thiols were quantified by 
dithionitrobenzoic acid (DTNB) labelling (see below). 100μL from each reaction was centrifuged at 15,000g for 
2 min, 50 μL of the supernatant was added to 50 mM Tris–HCL (pH 8.0), 0.4 mM DTNB in a final volume of 
200 μL. Reactions were measured at A412 nm in a Jenway 6305 spectrophotometer.
Steady state in vitro kinetics. In vitro activity assays were performed using an Epoch2 (BioTek) plate 
reader. Reactions were measured in 96-well plate. A continuous assay, described  previously3 was used to measure 
3M3SH. A 200 μL reaction contained 0.25 mM enzyme, variable amounts of substrate and 0.4 mM DTNB in 
50 mM KPi and 200 mM NaCl, pH 7.8. Cys-3M3SH substrate concentrations ranged from 2 to 7.8 mM. Each 
reaction was incubated at 37 °C for 30 min. Release of the thiol 3M3SH was measured by reaction with DTNB 
to form 2-nitro-5-thiobenzoic acid (TNB) which is measured at  A412  nm every minute. Background rate of 
DTNB decomposition was subtracted in each assay. Michaelis–Menten plots were derived from 6 to 8 substrate 
concentrations using Prism Version 5.01 (GraphPad) to calculate the Kcat and  KM. Enzyme concentrations were 
assumed to be the concentration of PLP-bound enzyme with two active sites per enzyme. Velocity curves for all 
in vitro kinetics are shown in the supplementary information (Supplementary Information Figures S10–S12).
Absorption spectroscopic analysis. The absorption spectrum between 300 and 600 nm of 25 μM puri-
fied ShPatB was initially determined at 10 nm intervals using a UV-transparent cuvette and the Epoch2 micro-
plate spectrophotometer (BioTek). 5 mM of Cys-3M3SH or the negative control, l-methionine, was then added 
to the cuvette. The absorption spectra were then collected again at 15 s intervals.
Crystallisation of ShPatB and BsPatB. Proteins were at 15 mg/mL in 20 mM Tris, pH8 and 50 mm 
NaCl. Crystals were grown in hanging drops (1:1 ratio) over 1 mL of the crystallisation solution (4% Tacsimate, 
pH 6 (Hampton Research) and 12% PEG 3,350) at room temperature in Corning Costar non-treated 24 well 
plates.
The condition was first identified using PEG/ION HT (Hampton Research) in 96 well MRC crystallisation 
plates. Shards of ShPatB crystals appeared overnight and were optimised in the 24 well plate format. ShPatB was 
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co-crystallised with LCS. 20 mM l-cycloserine was added to the crystallisation solution for  ShPatBLCS. Selected 
crystals were cryoprotected in 4% Tacsimate, pH 6, 12% PEG 3,350 and 20% glycerol. BsPatB was crystallised in 
a sitting drop (1:1 ratio) with 0.2 M Ammonium acetate, pH 7.1 and 20% PEG 3,350. Collected crystals of BsPatB 
were cryoprotected in 0.2 M Ammonium acetate, pH 7.1, 20% PEG 3,350 and 20% Glycerol.
Data collection and structure determination. X-ray diffraction data were collected at the Diamond 
Light Source, UK on beamline i03 for ShPatB and ShPatBLCS and beamline i04 for BsPatB. The data collected for 
ShPatB, ShPatBLCS and BsPatB were indexed and scaled using the XDS pipeline on the xia2. All data reductions 
were performed using AIMLESS 0.729 30. Molecular replacement was used to obtain initial phase information 
for all structurally characterised proteins in this study using the structure of a Clostridium difficile aminotrans-
ferase (PDB ID: 4DQ6) on  MOLREP36,37. The respective structures were refined using  REFMAC538. Refined 
coordinate sets and structure factors were deposited into the PDB with the entry codes 6QP2 for ShPatB, 6QP1 
for ShPatBLCS and 6QP3 for BsPatB. Data collection statistics are provided in Supplementary Information 
Table S5.
Cys-3M3SH ligand modelling. To describe how Cys-3M3SH could be coordinated, a structure of ShPatB 
docked with Cys-3M3SH in the l-cysteine form was created by rigid-body refinement. The atomic model and 
geometry dictionary for Cys-3M3SH were created in  AceDRG39 which were then used to dock the ligand onto 
the cycloserine bound structure of ShPatB (PDB ID: 6QP1) in  Coot40. The amino group of Cys-3M3SH was 
coordinated and anchored to atom N of the external aldimine, while the carboxyl group was coordinated to 
interact with Arg376. Using the restraints available in the ligand dictionary, the rest of the ligand was coordi-
nated to fit in the remaining space of the likely binding pocket while keeping the stereochemistry of the ligand 
and ensuring minimal clashes with the protein structure.
Phylogenetic analyses of PLP-dependent C-S lyases. To search for ShPatB homologs, its sequence 
(NCBI accession number WP_119633472.1) was used as the query for BLASTp (https ://www.ncbi.nlm.nih.gov/
BLAST /). We manually set a threshold of 30% sequence identity. Sequences were downloaded and aligned by 
MAFFT L-INS-i using Jalview. Phylogenetic analysis was performed by IQ-TREE. Phylogenetic tree was inferred 
by maximum likelihood with automatic model selection to find the best-fit model. Ultrafast bootstrap approxi-
mation was used give branch support. Phylogenetic trees were generated in iTOL (https ://itol.embl.de/).
Staphylococcus spp. core genome analysis. 53 representative strains of Staphylococcus sp. were down-
loaded from NCBI Assembly (Supplementary Information Table S8). The genome assemblies were annotated 
with PROKKA and provided as input to Roary. Roary was run using default parameters except for the following: 
-e -n (to produce alignments with MAFFT) and -i 80 (lower amino acid identity than the default). Maximum 
likelihood phylogeny was performed using RAxML. A general time-reversible nucleotide substitution model 
was used, with gamma-distributed rate heterogeneity across sites and 1,000 bootstrap replicates.
Time scaled Bayesian phylogenetic analysis. Bayesian phylogenetic analysis was performed using 
BEAST v2.5.241 using the Staphylococcus core genome nucleotide alignments as input data. A HKY model of 
nucleotide substitution with four gamma-distributed rate heterogeneity across sites. A calibrated Yule process of 
speciation and a strict clock model as priors with all other default values was used. A single calibration point was 
used to infer a temporal scale, the divergence time between Staphylococcus warneri and Staphylococcus pasteuri 
estimated from the TimeTree  database30 was used. The analysis was performed over three independent MCMC 
runs (10 million generations sampling every 1,000). Posterior distributions for parameter estimates and likeli-
hood scores to approximate convergence were visualized with the Tracer program (v1.6.042). Visual inspection 
of traces within and across runs, as well as the effective sample sizes ESS) of each parameter (> 200), allowed us 
to confirm that the analysis was adequately sampled. A maximum clade credibility (MCC) tree was chosen by 
TreeAnnotator (v1.8.141) for each independent run after a 10% burn-in. MCC trees were visualized with FigTree 
v1.4.4.
Data availability
Atomic coordinates have been deposited in the protein data bank (PDB) under the accession number 6QP1—
Staphylococcus hominis PatB in the external aldimine in complex with l-cycloserine. 6QP2—Staphylococcus 
hominis PatB and 6QP3—crystal structure of the PLP-bound C-S lyase from Bacillus subtilis 168.
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